1. Homepage
  2. Equities
  3. Finland
  4. Nasdaq Helsinki
  5. Nanoform Finland Oyj
  6. Summary
    NANOFH   FI4000330972

NANOFORM FINLAND OYJ

(NANOFH)
  Report
Delayed Nasdaq Helsinki  -  11:29 2022-08-09 am EDT
3.695 EUR   +0.54%
07/14Nanoform and Pharmanovia to breathe new life into iconic medicines
AQ
07/14Nanoform Finland Plc Partners with Pharmanovia for Iconic Medicines
CI
06/13Nanoform Chief of Business Operations Gonçalo Andrade steps down
AQ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Helsinki
08/03/2022 08/04/2022 08/05/2022 08/08/2022 08/09/2022 Date
3.66(c) 3.645(c) 3.695(c) 3.675(c) 3.695(c) Last
19 514 4 004 2 837 1 824 12 618 Volume
+2.66% -0.41% +1.37% -0.54% +0.54% Change
More quotes
Estimated financial data (e)
Sales 2022 7,00 M 7,15 M 7,15 M
Net income 2022 -18,7 M -19,1 M -19,1 M
Net cash position 2022 74,4 M 76,0 M 76,0 M
P/E ratio 2022 -14,7x
Yield 2022 -
Sales 2023 19,4 M 19,8 M 19,8 M
Net income 2023 -11,4 M -11,7 M -11,7 M
Net cash position 2023 61,6 M 62,9 M 62,9 M
P/E ratio 2023 -24,5x
Yield 2023 -
Capitalization 288 M 294 M 294 M
EV / Sales 2022 30,5x
EV / Sales 2023 11,7x
Nbr of Employees 130
Free-Float 74,7%
More Financials
Company
Nanoform Finland Oyj is a Finland-based limited liability Company offering services in nanotechnology and drug particle engineering for the international pharma industry. The Company’s affairs consist of both internal research and development activities and proof of concept type of research and development services provided to customers. 
Sector
Pharmaceuticals
Calendar
08/25Earnings Release
More about the company
Ratings of Nanoform Finland Oyj
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about NANOFORM FINLAND OYJ
07/14Nanoform and Pharmanovia to breathe new life into iconic medicines
AQ
07/14Nanoform Finland Plc Partners with Pharmanovia for Iconic Medicines
CI
06/13Nanoform Chief of Business Operations Gonçalo Andrade steps down
AQ
06/13Nanoform's Gonçalo Andrade Steps Down as Chief of Business Operations
CI
06/13Nanoform Finland Plc - Manager's transactions - Jeanne Thoma
AQ
06/13Nanoform Finland Plc - Manager's transactions - Albert Hæggström
AQ
06/13Nanoform Finland Plc - Manager's transactions - Mads Laustsen
AQ
06/06Share subscriptions based on Nanoform Finland Plc's stock options 1-2/2019 and 1/2020
AQ
06/06The Board of Directors of Nanoform Finland Plc decided on issue of stock options to key..
AQ
06/06Nanoform Finland Plc - Manager's transactions - Miguel Calado
AQ
06/02NANOFORM FINLAND OYJ : Plc – Manager's transactions – Niklas Sandler
PU
06/02Nanoform Finland Plc - Manager's transactions - Niklas Sandler
AQ
05/30Nanoform Finland Plc - Manager's transactions - Gonçalo Andrade
AQ
05/24TRANSCRIPT : Nanoform Finland Oyj, Q1 2022 Earnings Call, May 24, 2022
CI
05/24NANOFORM 1Q 2022 REPORT : Quarterly record of new projects and new customers
AQ
More news
News in other languages on NANOFORM FINLAND OYJ
07/14Nanoform Finland Plc s'associe à Pharmanovia pour des médicaments emblématiques
06/13Gonçalo Andrade, de Nanoform, quitte son poste de chef des opérations commerciales
05/24Nanoform Finland Oyj annonce ses résultats pour le premier trimestre clos le 31 mars 20..
05/04Nanoform Finland Plc. Lancement de "STARMAP® Online" plaçant la puissance de l'IA au bo..
04/12Nanoform Finland élit des membres au comité d'audit et de rémunération
More news
Chart NANOFORM FINLAND OYJ
Duration : Period :
Nanoform Finland Oyj Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NANOFORM FINLAND OYJ
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 3,68 €
Average target price 8,88 €
Spread / Average Target 141%
EPS Revisions
Managers and Directors
Edward Hæggström Chief Executive Officer
Albert Häggström Chief Financial Officer & Director
Miguel Maria de Oliveira Barreiros Calado Chairman
Niklas Sandler Chief Technology Officer
Gonçalo Nuno N. da Silva Rebelo de Andrade Chief Business Operations
Sector and Competitors
1st jan.Capi. (M$)
NANOFORM FINLAND OYJ-44.15%294
JOHNSON & JOHNSON0.02%447 486
ELI LILLY AND COMPANY9.51%287 428
PFIZER, INC.-16.56%278 132
ROCHE HOLDING AG-16.68%273 741
ABBVIE INC.1.95%248 135